According to the new market research report Pharmaceutical Analytics Software market is expected to reach 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period of 2020 to 2025.
Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales & marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653
The Pharmaceutical Analytics Software market is a highly diversified and competitive market, with a large number of players, including mid-tier companies and startup firms, competing for market shares. SAS Institute, Inc. (US), Oracle Corporation (US), IBM Corporation (US), Quintiles, Inc. (US), Accenture (Ireland), Cognizant (US), Wipro (India), MaxisIT, Inc. (US), TAKE Solutions (India), and SCIO Health Analytics (US) are some of the key players in this market. These players have adopted various growth strategies, such as product launches & upgrades; expansions; mergers & acquisitions; and partnerships, agreements, and collaborations, to further expand their presence in the global market.
Agreements, partnerships, and collaborations were the key growth strategies adopted by players from 2017 to 2020. Some of the leading players who adopted these strategies are SAS Institute (US), Wipro Limited (India), Accenture (Ireland), IBM Corporation (US), and IQVIA (US).
IBM Corporation (US)
IBM Corporation is one of the leading players in the life science analytics market. The company’s strong position in the market can be attributed to its brand recognition and extensive product offerings. The company focuses on inorganic as well as organic growth strategies such as acquisitions, collaborations, expansions, and product launches in order to expand its existing product portfolio and strengthen its market position. For instance, in June 2017, IBM and Cornell University announced a new collaboration using next-generation sequencing combined with big data analytics. In February 2017, the company launched the Watson Platform for Health Cloud and a specialized Watson Health Consulting Services unit. Such developments are expected to help the company to maintain its strong presence in the market.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174990653
Oracle Corporation (US)
Oracle, with its broad customer base of over 430,000 customers and geographic presence in over 175 countries, is a key player in a range of IT software, hardware, and service-related markets, including the life science analytics market. The company focuses on continuously updating its products and meeting customer expectations. To provide tailored solutions, Oracle is continuously investing in expanding its cloud-based solutions segment. For instance, in April 2016, the company launched a cloud version of the Oracle Health Sciences Safety Suite 8.0 for pharmaceutical companies.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062